Biggest News Aggregation in the World
📰 Highest News

Page 776 - Highest News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Highest. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Sangamo Therapeutics, Inc.: Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Bleeding Control in Highest Dose Cohort Through Two Years Following Hemophilia A Gene Therapy

Pfizer Inc. (NYSE: PFE) andSangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today announced updated follow-up data from the Phase 1/2 Alta study of giroctocogene fitelparvovec
United States Aaron Feingold Sengh Cheng Rob Schott Drug Administration American Society For Hematology Annual Meeting

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science